# Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer

> **NCT06751394** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 44 (estimated)

## Conditions studied

- Recurrent Rectal Cancer

## Interventions

- **DRUG:** PD-1 antibody (Toripalimab)
- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan
- **RADIATION:** Radiation
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT06751394
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06751394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06751394, "Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06751394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*